503b glp-1 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of medications like semaglutide and tirzepatide, signaling a major shift in how these The FDA fired a warning

The rise of GLP-1 medications prescribed via telehealth, including tirzepatide (Mounjaro, Zepbound), semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), has produced positive results for many individuals

Second, although the current study provides a chemical characterization of the phytotherapeutic agents used, it does not determine whether a specific biomarker of Ganoderma lucidum is present in liver tissue

In fact, propionic acid-producing bacteria, such as Fusobacterium nucleatum , have been positively correlated with meningococcal abundance (Retchless et al., 2020), in line with the proposed propionic acid cross-feeding mechanism (Catenazzi et al., 2014)

doi: 10.1038/ejcn.2017.132 263 SotoM